Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in EDIT — Editas Medicine, Inc.

CIK 873630 LONDON, X0
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$314,480
+$37,381 QoQ
Shares Held
97,062
-13.5% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 216 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. EDIT ranks #85 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 676,247 $335,912,169
2 REGN
Regeneron Pharmaceuticals, Inc.
 382,028 $238,209,735
3 INCY
Incyte Corp
 1,307,743 $148,245,744
4 RPRX
Royalty Pharma plc
 1,224,925 $68,681,542
5 MRNA
Moderna, Inc.
 636,199 $44,553,014
6 ALNY
Alnylam Pharmaceuticals, Inc.
 115,279 $34,702,435
7 INSM
INSMED Inc
 279,961 $29,849,438
8 BMRN
Biomarin Pharmaceutical Inc
 307,543 $17,597,610

All Filings in EDIT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $314,480 97,062
2026-03-31 $277,099 112,186
2025-12-31 $229,981 112,186
2025-09-30 $332,766 95,898
2025-06-30 $116,661 53,028
2025-03-31 $67,643 58,313
2024-12-31 $74,137 58,376
2024-09-30 $193,179 56,651
2024-06-30 $489,387 104,794
2024-03-31 $313,368 42,233
2023-12-31 $319,469 31,537
2023-09-30 $243,632 31,235
2023-06-30 $103,969 12,633
2023-03-31 $103,624 14,293
2020-09-30 $369,774 13,178